Sort
46,585 grants matching “heart failure”
Neurohumoral control of veins in hypertension
$1,733,230Gregory D Fink · Michigan State University · P01 · FY2006 · HL
Vaso-Hormonal Mechanisms in Hypertension
$1,732,726Carlos M Ferrario · Wake Forest University Health Sciences · P01 · FY2018 · HL
Drug Metabolizing Enzymes In Humans And Animal Models
$1,730,997Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Development of transapical MVAD for heart failure therapy
$1,729,014Daniel Tamez · Heartware, Inc. · R44 · FY2013 · HL
Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery
$1,728,439Lynne A Bui · Khloris Biosciences, Inc. · R44 · FY2022 · HL
Washington University Institute of Clinical and Translational Sciences (KL2)
$1,728,410Kenneth S Polonsky · Washington University · KL2 · FY2009 · RR
Neurohumoral control of veins in hypertension
$1,723,052Michigan State University · P01 · FY2005 · HL
Center of Excellence in Gene Therapy(PROGRAM PROJECT)
$1,722,809Caritas St. Elizabeth'S Medical Center · P01 · FY2003 · HL
Novel Mechanisms and Therapies in Heart Failure
$1,722,136Howard A Rockman · Duke University · P01 · FY2015 · HL
Determinants and Cardiovascular Consequences of Diabetes in Older Adults
$1,720,863Kenneth Jay Mukamal · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
Adult Stem Cell Therapy For Cardiac Failure
$1,720,861Neal David Epstein · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL
Task Order One (1) shall encompass conduct of and support for core study operations, data analysis, manuscript preparation, and morbidity and mortality ascertainment. The Field Center shall contact su
$1,718,457Adolfo Correa · University Of Mississippi Med Ctr · N01 · FY2022 · HL
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
$1,717,926Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2025 · HL
Therapeutic Targeting of Carotid Body Chemoreflex for Sleep Disordered Breathing
$1,716,511Nanduri R Prabhakar · University Of Chicago · UH3 · FY2017 · HL
Objective Physical Activity and Cardiovascular Health in Older Women: OPACH2
$1,715,829Andrea Z. Lacroix · University Of California, San Diego · R01 · FY2023 · HL
CARDIOVASCULAR DYNAMICS AND THEIR CONTROL
$1,714,963University Of Mississippi Medical Center · P01 · FY2001 · HL
National Center for In Vivo Metabolism
$1,714,127Craig R. Malloy · Ut Southwestern Medical Center · P41 · FY2017 · EB
Adaptation to Hypoxia
$1,713,823Kurt R Stenmark · University Of Colorado Denver · P01 · FY2015 · HL
System Biology Center in New York
$1,712,668Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · P50 · FY2014 · GM
Safety and efficacy of Belatacept in heart transplantation
$1,710,716Marlena Habal · New York University School Of Medicine · U01 · FY2025 · AI
IGF::OT::IGF
$1,710,693James Shikany · University Of Alabama At Birmingham · N01 · FY2013 · HL
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE
$1,708,700University Of Cincinnati · P50 · FY2000 · HL
Cardiac Energy Metabolism in Heart Failure
$1,707,226Case Western Reserve University · P01 · FY2003 · HL
Signaling Processes Underlying Cardiovascular Function
$1,706,890Jeffrey Robbins · Cincinnati Childrens Hosp Med Ctr · P01 · FY2013 · HL
Vaso-Hormonal Mechanisms in Hypertension
$1,706,717Carlos M Ferrario · Wake Forest University Health Sciences · P01 · FY2016 · HL